Is there a relationship between glycemic control and morbi-mortality after 5 years in type 2 diabetic patients 70 years and older? Rationale for a first prospective study;Existe-t-il un lien entre l'équilibre glycémique et la morbi-mortalité chez les diabétiques de type 2 de plus de 70 ans? Intérêt de la mise en place d'une première étude prospective

Medecine des Maladies Metaboliques

Volumn 3, Issue 2, 2009, Pages 203-206

  Doucet, Jean ^b   Bauduceau, B ^a   Le Floch, J P ^a   Verny, C ^a   Blickle J F ^a   Bourdel Marchasson, I ^a   Brocker, P ^a   Constans, T ^a   Fagot Campagna, A ^a   Kaloustian, E ^a   Lassmann Vague, V ^a   Lecomte, P ^a   Simon, D ^a   Tessier, D ^a   Tramoni, M ^a   Vischer, U M ^a  

^a CHU de Rouen ^*

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Diabetes in elderly; Glycemic control; Morbi mortality; Prospective study

Indexed keywords

HEMOGLOBIN A1C;

AGE; CARDIOVASCULAR RISK; GLYCEMIC CONTROL; HUMAN; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; REVIEW;

EID: 62249195562     PISSN: 19572557     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1957-2557(09)71646-3     Document Type: Article

References (18)

1. Fagot-Campana A, Bourdel-Marchasson I, Simon D. Burden of diabetes in an ageing population: prevalence, incidence, mortality, characteristics and quality of care. Diabetes Metab 2005;31(Special issue 2):5S35-5S52.
2. Bourdel-Marchasson I, Dubroca B, Manciet G, et al. Prevalence of diabetes and effect on quality of life in older French living in the community: the PAQUID Epidemiological Survey. J Am Geriat Soc 1997;45:295-301.
3. Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Diabète traité en France en 2007 : un taux de prévalence proche de 4 % et des disparités géographiques croissantes. Bull Epidémiol Hebdo (BEH) 2008;43:409-13.
4. Kusnik-Joinville O, Weill A, Salanave B, et al. Prevalence and treatment of diabetes in France: trends between 2000 and 2005. Diabetes Metab 2008;34:266-72.
5. Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
6. Blicklé JF, Doucet J, Krummel T, Hannedouche T. Diabetic nephropathy in the elderly. Diabetes Metab 2007;33(Suppl.1):S40-S55.
7. Doucet J, Druesne L, Capet C, et al. Risks factors and management of diabetes in elderly French patients. Diabetes Metab 2008;34:574-80.
8. Goldberg RB, Mellies MJ, Sacks FM, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. Circulation 1998;98:2513-9.
9. Huang ES, Zhang Q, Gandra N, et al. The effect of comorbid illness and functional status on the expected benefits of intensive glucose control in older patients with type 2 diabetes: a decision analysis. Ann Intern Med 2008;149:11-9.
10. Lassmann-Vague V. Hypoglycaemia in elderly diabetic patients. Diabetes Metab 2005;31(Special issue 2):5S53-5S57.
11. Intergroupe francophone de Diabéto-Gériatrie ALFEDIAM-SFGG. Diabetes in the elderly patients. Diabetes Metab 2005;31(Special issue 2):5S7-5S111.
12. Intergroupe francophone de Diabéto-Gériatrie ALFEDIAM-SFGG. Diabetes in the elderly. Part 2. Diabetes Metab 2007;33(Suppl.1):S1-S86.
13. Maraldi C, Volpato S, Penninx BW, et al. Diabetes mellitus, glycemic control, and incident depressive symptoms among 70- to 79-year-old persons: the health, aging, and body composition study. Arch Intern Med 2007;167:1137-44.
14. Blicklé JF, Attali JR, Barrou Z, et al. Le diabète du sujet âgé. Rapport du groupe d'experts de l'ALFEDIAM et de la Société Française de Gérontologie. Diabetes Metab 1999;25:84-93.
15. European Diabetes Working Party of older people 2001-2004. Clinical Guidelines for type 2 diabetes mellitus. May 2004. www.eugms.org/academic/ guidelines.
16. Constans T. Plasma glucose goals and therapeutic management in elderly diabetic patients. Diabetes Metab 2005;31(Special issue 2):5S58-5S61.
17. AFSSAPS-HAS. Recommandation Professionnelle. Traitement médicamenteux du diabète de type 2 (Actualisation). Novembre 2006. Recommandation de Bonne Pratique (Synthèse, Recommandation et Argumentaire). Diabetes Metab 2007;33:1S1-1S105. www.hassante.fr
18. ère édition. Médecine des maladies Métaboliques 2008;2(Hors-série 1);S1-S121.